These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35762631)

  • 21. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs.
    Farkouh ME; Greenberg BP
    Am J Cardiol; 2009 May; 103(9):1227-37. PubMed ID: 19406264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Helicobacter pylori and eradication therapy on gastrointestinal permeability. Implications for patients with seronegative spondyloarthritis.
    Di Leo V; D'Inca R; Bettini MB; Podswiadek M; Punzi L; Mastropaolo G; Sturniolo GC
    J Rheumatol; 2005 Feb; 32(2):295-300. PubMed ID: 15693091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents.
    Chan FK; Abraham NS; Scheiman JM; Laine L;
    Am J Gastroenterol; 2008 Nov; 103(11):2908-18. PubMed ID: 18853980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of Gastrointestinal and Cardiovascular Risk in Patients with Degenerative Lumbar Spinal Disease.
    Yang JH; Lee BH; Eum KS; Suk KS; Park JO; Kim HS; Lee HM; Moon SH
    Clin Orthop Surg; 2020 Sep; 12(3):343-352. PubMed ID: 32904035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of treatment options for spondyloarthritis: a narrative review.
    D'Angelo S; Carriero A; Gilio M; Ursini F; Leccese P; Palazzi C
    Expert Opin Drug Saf; 2018 May; 17(5):475-486. PubMed ID: 29505325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ischaemic cardiovascular risk and prescription of non-steroidal anti-inflammatory drugs for musculoskeletal complaints.
    Koffeman AR; Valkhoff VE; Jong GW; Warlé-van Herwaarden MF; Bindels PJ; Sturkenboom MC; Luijsterburg PA; Bierma-Zeinstra SM
    Scand J Prim Health Care; 2014 Jun; 32(2):90-8. PubMed ID: 24931511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nonsteroidal anti-inflammatory drugs: cardiovascular, cerebrovascular and renal effects].
    Batlouni M
    Arq Bras Cardiol; 2010 Apr; 94(4):556-63. PubMed ID: 20498929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased Risk of Hypertension Associated with Spondyloarthritis Disease Duration: Results from the ASAS-COMOSPA Study.
    Derakhshan MH; Goodson NJ; Packham JC; Sengupta R; Molto A; Marzo-Ortega H; Siebert S;
    J Rheumatol; 2019 Jul; 46(7):701-709. PubMed ID: 30647169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Balancing cardiovascular and gastrointestinal risks in patients with osteoarthritis receiving nonsteroidal anti‑inflammatory drugs. A summary of guidelines from an international expert group.
    Mosleh W; Farkouh ME
    Pol Arch Med Wewn; 2016; 126(1-2):68-75. PubMed ID: 26810416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDA labeling of NSAIDs: Review of nonsteroidal anti-inflammatory drugs in cardiovascular disease.
    Pirlamarla P; Bond RM
    Trends Cardiovasc Med; 2016 Nov; 26(8):675-680. PubMed ID: 27238053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.
    White WB; West CR; Borer JS; Gorelick PB; Lavange L; Pan SX; Weiner E; Verburg KM
    Am J Cardiol; 2007 Jan; 99(1):91-8. PubMed ID: 17196469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: Evidence from real-life setting trials and surveys.
    Pelletier JP; Martel-Pelletier J; Rannou F; Cooper C
    Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S22-7. PubMed ID: 26806184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone loss in patients with early inflammatory back pain suggestive of spondyloarthritis: results from the prospective DESIR cohort.
    Briot K; Etcheto A; Miceli-Richard C; Dougados M; Roux C
    Rheumatology (Oxford); 2016 Feb; 55(2):335-42. PubMed ID: 26361878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxicological considerations in the treatment of axial spondylo-arthritis.
    Marino F; D'Angelo S; Masala IF; Gerratana E; Nucera V; La Corte L; Giallanza M; Sarzi-Puttini P; Atzeni F
    Expert Opin Drug Metab Toxicol; 2020 Aug; 16(8):663-672. PubMed ID: 32552128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of Etoricoxib, Celecoxib, and Nonselective Nonsteroidal Antiinflammatory Drugs in Ankylosing Spondylitis and Other Spondyloarthritis Patients: A Swedish National Population-Based Cohort Study.
    Kristensen LE; Jakobsen AK; Askling J; Nilsson F; Jacobsson LT
    Arthritis Care Res (Hoboken); 2015 Aug; 67(8):1137-49. PubMed ID: 25623277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brief Report: Six-Week Treatment of Axial Spondyloarthritis Patients With an Optimal Dose of Nonsteroidal Antiinflammatory Drugs: Early Response to Treatment in Signal Intensity on Magnetic Resonance Imaging of the Sacroiliac Joints.
    Varkas G; Jans L; Cypers H; Van Praet L; Carron P; Elewaut D; Van den Bosch F
    Arthritis Rheumatol; 2016 Mar; 68(3):672-8. PubMed ID: 26473982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute anterior uveitis and other extra-articular manifestations of spondyloarthritis.
    Mitulescu TC; Popescu C; Naie A; Predeţeanu D; Popescu V; Alexandrescu C; Voinea LM
    J Med Life; 2015; 8(3):319-25. PubMed ID: 26351533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis.
    Lanas A; Garcia-Tell G; Armada B; Oteo-Alvaro A
    BMC Med; 2011 Apr; 9():38. PubMed ID: 21489310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular morbidity and mortality in patients with spondyloarthritis: A meta-analysis.
    Kim JH; Choi IA
    Int J Rheum Dis; 2021 Apr; 24(4):477-486. PubMed ID: 32969177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonsteroidal anti-inflammatory drugs exposure and the central nervous system.
    Auriel E; Regev K; Korczyn AD
    Handb Clin Neurol; 2014; 119():577-84. PubMed ID: 24365321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.